Skip to content
healthcare.dev
Get a free key

Guaifenesin and Pseudoephedrine HCl

NDC 46122-801, Guaifenesin and Pseudoephedrine HCl, tablet, extended release, from Amerisource Bergen.

Product NDC
46122-801
Status
Listed
Labeler
Amerisource Bergen
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA213203
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/46122-801 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GUAIFENESIN600 mg/1
  • PSEUDOEPHEDRINE HYDROCHLORIDE60 mg/1

Pharmacologic classes

Adrenergic alpha-Agonists [MoA]; Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]; alpha-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
46122-801-08461220801081 BLISTER PACK in 1 CARTON (46122-801-08) / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 46122-801 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/46122-801 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 46122-801. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.